Furthermore, valproic acid treatment attenuated diabetes-induced upregulation of C5ar2. While we have previously demonstrated a pathological role for C5aR1 in DKD, the role of C5aR2 is currently unknown. This evidence concerns the gene C5AR1 and diabetic kidney disease.